{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:13:47Z","timestamp":1746677627089,"version":"3.40.5"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["UJAN"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Nursing professionals are vitally involved in the cascade of care for opioid use disorders (OUDs). The global spread of COVID-19 has had complex effects on public health aspects of major diseases, including OUDs. There are limited data on the major ways in which the COVID-19 pandemic has affected the functions of nursing professionals in the care of OUDs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>This systematic review followed Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines and examined published data for trends in OUD care during the first 2 years of the COVID-19 pandemic, focusing on nursing functions. The National Library of Medicine PubMed database and the EMBASE database were examined for peer-reviewed studies with primary data published between January 1, 2020, and December 31, 2021.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Review Findings and Conclusions<\/jats:title>\n            <jats:p>Rapid changes were observed in numerous aspects of OUDs during the early pandemic stage, as well as its care by nursing and other health professionals. These changes include increased overdoses (primarily from synthetic opioids such as fentanyl) and emergency department visits. These trends varied considerably across U.S. jurisdictions, underscoring the importance of region-specific examinations for public health policy and intervention. Out of necessity, healthcare systems and nursing professionals adapted to the challenges of OUD care in the pandemic. These adaptations included increases in telehealth services, increases in take-home doses of methadone or buprenorphine\/naloxone, and expansion of layperson training in the use of naloxone for overdose reversal. It is likely that some of these adaptations will result in long-term changes in standards of care practices for OUDs by nursing professionals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/jan.0000000000000573","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:00:42Z","timestamp":1717239642000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of the COVID-19 Pandemic on Functions of Nursing Professionals in the Care of Opioid Use Disorder"],"prefix":"10.1097","volume":"35","author":[{"given":"Kate G.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R.","family":"Butelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"bib2-20250507","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12954-021-00572-7","article-title":"Telehealth for opioid use disorder treatment in low-barrier clinic settings: An exploration of clinician and staff perspectives","volume":"18","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"16","key":"bib4-20250507","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/acschemneuro.0c00349","article-title":"Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19","volume":"11","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"issue":"11","key":"bib5-20250507","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/brainsci10110895","article-title":"U-47700 and its analogs: Non-fentanyl synthetic opioids impacting the recreational drug market","volume":"10","year":"2020","journal-title":"Brain Sciences"},{"key":"bib6-20250507","first-page":"103554","article-title":"The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months","volume":"101","year":"2021","journal-title":"The International Journal on Drug Policy"},{"key":"bib7-20250507","first-page":"374","article-title":"Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: Results from a National Survey","volume":"73","year":"2021","journal-title":"Psychiatric Services"},{"issue":"7","key":"bib8-20250507","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","article-title":"Treatment of opioid overdose: Current approaches and recent advances","volume":"239","year":"2022","journal-title":"Psychopharmacology"},{"key":"bib9-20250507","doi-asserted-by":"crossref","first-page":"947603","DOI":"10.3389\/fpsyt.2022.947603","article-title":"Has the United States reached a plateau in overdoses caused by synthetic opioids after the onset of the COVID-19 pandemic? Examination of Centers for Disease Control and Prevention data to November 2021","volume":"13","year":"2022","journal-title":"Front Psychiatry"},{"key":"bib10-20250507","first-page":"196","article-title":"Implementation of office-based buprenorphine treatment for opioid use disorder","volume":"34","year":"2021","journal-title":"Journal of the American Association of Nurse Practitioners"},{"key":"bib12-20250507","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment","volume":"106","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"4","key":"bib13-20250507","doi-asserted-by":"crossref","first-page":"e216147","DOI":"10.1001\/jamanetworkopen.2021.6147","article-title":"Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic","volume":"4","year":"2021","journal-title":"JAMA Network Open"},{"key":"bib14-20250507","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ALN.0000000000003848","article-title":"Functional profile of systemic and intrathecal cebranopadol in nonhuman primates","volume":"135","year":"2021","journal-title":"Anesthesiology"},{"issue":"4","key":"bib15-20250507","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1108\/IntR-03-2018-0089","article-title":"The value of online surveys: A look back and a look ahead","volume":"28","year":"2018","journal-title":"Internet Research"},{"issue":"2","key":"bib16-20250507","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40429-021-00368-6","article-title":"New and emerging opioid overdose risk factors","volume":"8","year":"2021","journal-title":"Current Addiction Reports"},{"key":"bib17-20250507","doi-asserted-by":"crossref","first-page":"108811","DOI":"10.1016\/j.drugalcdep.2021.108811","article-title":"Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey","volume":"225","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"bib18-20250507","first-page":"578","article-title":"Countermeasures for preventing and treating opioid overdose","volume":"109","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"bib19-20250507","doi-asserted-by":"crossref","first-page":"103199","DOI":"10.1016\/j.drugpo.2021.103199","article-title":"A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic","volume":"94","year":"2021","journal-title":"The International Journal on Drug Policy"},{"issue":"2","key":"bib20-20250507","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11524-022-00610-0","article-title":"Impact of the COVID-19 pandemic on opioid overdose deaths: A spatiotemporal analysis","volume":"99","year":"2022","journal-title":"Journal of Urban Health"},{"key":"bib21-20250507","doi-asserted-by":"crossref","first-page":"109049","DOI":"10.1016\/j.drugalcdep.2021.109049","article-title":"The impact of COVID-19 on opioid treatment programs in the United States","volume":"228","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"bib22-20250507","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11524-020-00465-3","article-title":"A community responds to the COVID-19 pandemic: A case study in protecting the health and human rights of people who use drugs","volume":"97","year":"2020","journal-title":"Journal of Urban Health"},{"key":"bib23-20250507","doi-asserted-by":"crossref","first-page":"108288","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"23","key":"bib24-20250507","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1001\/jama.2020.21512","article-title":"Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic","volume":"324","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"bib25-20250507","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11606-021-07174-w","article-title":"Initiating opioid use disorder medication via telemedicine during COVID-19: Implications for proposed reforms to the Ryan Haight act","volume":"37","year":"2022","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"bib26-20250507","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5055\/jom.2021.0608","article-title":"Tales from the frontlines: An alarming rise in hospitalizations related to opioid use disorder in the era of COVID-19","volume":"17","year":"2021","journal-title":"Journal of Opioid Management"},{"key":"bib27-20250507","doi-asserted-by":"crossref","first-page":"107616","DOI":"10.1016\/j.drugalcdep.2019.107616","article-title":"Characteristics and current clinical practices of opioid treatment programs in the United States","volume":"205","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"bib28-20250507","doi-asserted-by":"crossref","first-page":"108783","DOI":"10.1016\/j.drugalcdep.2021.108783","article-title":"Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic","volume":"225","year":"2021","journal-title":"Drug Alcohol and Dependence"},{"issue":"7","key":"bib29-20250507","doi-asserted-by":"crossref","first-page":"e2118223","DOI":"10.1001\/jamanetworkopen.2021.18223","article-title":"Methadone access for opioid use disorder during the COVID-19 pandemic within the United States and Canada","volume":"4","year":"2021","journal-title":"JAMA Network Open"},{"key":"bib31-20250507","doi-asserted-by":"crossref","first-page":"100237","DOI":"10.1016\/j.lana.2022.100237","article-title":"Sociodemographic and geographic disparities in excess fatal drug overdoses during the COVID-19 pandemic in California: A population-based study","volume":"11","year":"2022","journal-title":"Lancet Regional Health Americas"},{"issue":"10","key":"bib32-20250507","doi-asserted-by":"crossref","first-page":"eaax9140","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","year":"2019","journal-title":"Science Advances"},{"issue":"3","key":"bib33-20250507","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"bib34-20250507","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","article-title":"Telemedicine-delivered treatment interventions for substance use disorders: A systematic review","volume":"101","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"123","key":"bib35-20250507","first-page":"e2022134118","article-title":"Neural basis of opioid-induced respiratory depression and its rescue","volume":"118","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"bib36-20250507","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/JAN.0000000000000355","article-title":"Caring for patients with opioid use disorder in the midst of a pandemic: A call to action for all nurses","volume":"31","year":"2020","journal-title":"Journal of Addictions Nursing"},{"issue":"2","key":"bib37-20250507","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08897077.2021.1890676","article-title":"COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management","volume":"42","year":"2021","journal-title":"Substance Abuse"},{"issue":"6","key":"bib38-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.JAA.0000742976.14811.36","article-title":"Opioid use disorder and COVID-19: Implications for policy and practice","volume":"34","year":"2021","journal-title":"JAAPA"},{"key":"bib39-20250507","doi-asserted-by":"crossref","first-page":"106603","DOI":"10.1016\/j.ypmed.2021.106603","article-title":"The intertwined expansion of telehealth and buprenorphine access from a prescriber hub","volume":"152","year":"2021","journal-title":"Preventive Medicine"},{"issue":"7","key":"bib40-20250507","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/appi.ajp.2020.20060816","article-title":"Sublingual buprenorphine\u2013naloxone compared with injection naltrexone for opioid use disorder: Potential utility of patient characteristics in guiding choice of treatment","volume":"178","year":"2021","journal-title":"The American Journal of Psychiatry"},{"key":"bib41-20250507","doi-asserted-by":"crossref","first-page":"619683","DOI":"10.3389\/fsoc.2021.619683","article-title":"Community case study of naloxone distribution by hospital-based harm reduction program for people who use drugs in New York City","volume":"6","year":"2021","journal-title":"Frontiers in Sociology"},{"key":"bib42-20250507","doi-asserted-by":"crossref","first-page":"108977","DOI":"10.1016\/j.drugalcdep.2021.108977","article-title":"The impact of the National Stay-at-Home Order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic","volume":"228","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"bib43-20250507","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/10826084.2020.1791184","article-title":"Opioid use disorder and COVID-19: Biological plausibility for worsened outcomes","volume":"55","year":"2020","journal-title":"Substance Use & Misuse"},{"key":"bib44-20250507","first-page":"108019","article-title":"Treatment of overdose in the synthetic opioid era","volume":"233","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"bib45-20250507","doi-asserted-by":"crossref","first-page":"108176","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data","volume":"214","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"bib46-20250507","first-page":"100559","article-title":"A novel transition: Lessons learned during rapid implementation and evolution of telehealth group based opioid treatment (t-GBOT) during the COVID-19 pandemic","volume":"9","year":"2021","journal-title":"Healthcare (Amsterdam, Netherlands)"},{"key":"bib47-20250507","first-page":"30","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"bib48-20250507","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000542-199207000-00022","article-title":"Elucidation of dose\u2013effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat","volume":"77","year":"1992","journal-title":"Anesthesiology"},{"issue":"1","key":"bib49-20250507","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/ADM.0000000000000834","article-title":"Social determinants of mortality of COVID-19 and opioid overdose in American rural and urban counties","volume":"16","year":"2022","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Addictions Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JAN.0000000000000573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T20:01:28Z","timestamp":1746648088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JAN.0000000000000573"}},"subtitle":["Systematic Review"],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/jan.0000000000000573","relation":{},"ISSN":["1548-7148","1088-4602"],"issn-type":[{"type":"electronic","value":"1548-7148"},{"type":"print","value":"1088-4602"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}